PuraStat in gastrointestinal bleeding: results of a prospective multicentre observational pilot study.
Federica BranchiRolf Klingenberg-NoftzKristina FriedrichNataly BürgelSeverin DaumJuliane BuchkremerElena SonnenbergMichael SchumannChristoph TreeseHanno TrögerDonata LissnerHans-Jörg EppleBritta SiegmundAndrea StrouxAndreas AdlerWinfried Veltzke-SchliekerDaniel AutenriethSilke LeonhardtAndreas FischerChristian JürgensenUlrich-Frank PapeBertram WiedenmannOliver MöschlerMaximilian SchreinerMathias Z StrowskiVolkmar HempelYvonne HuberHelmut NeumannChristian BojarskiPublished in: Surgical endoscopy (2021)
PuraStat expanded the therapeutic toolbox available for an effective treatment of gastrointestinal bleeding sources. It could be safely applied and administered without complications as a primary or secondary therapy. PuraStat may additionally serve as a bridge to surgery in order to achieve temporary haemostasis in case of refractory severe bleeding, possibly playing a role in preventing immediate emergency surgery.